Search results for "Lymph nodes"

showing 10 items of 203 documents

Carcinoma of the neovagina: case report and review of the literature.

2001

Abstract Background. Carcinoma of the vagina is a rare disease, and it is even more rare in the neovagina. Nevertheless, it has been well described. The aim of this report was to analyze the reported cases and to add observations concerning a risk profile for this rare occurrence of carcinoma. Case report. The 29-year-old patient's history included congenital absence of vagina as a result of Rokitansky–Kuster syndrome. In 1987, when the patient was 17 years old, a neovagina was constructed by dissection between the bladder and the rectum, according to the Warthon method, and the apex of the neovagina was covered with Dura-mater. In 1990 the patient underwent radiation treatment with brachyt…

Adultmedicine.medical_specialtyVaginal NeoplasmsSurgically-Created Structures03 medical and health sciences0302 clinical medicineParaaortic lymph nodesCarcinomaMedicineHumans030219 obstetrics & reproductive medicineUrinary bladderbusiness.industryObstetrics and GynecologyGranulation tissuemedicine.disease3. Good healthSurgeryDissectionmedicine.anatomical_structureOncologyEpidermoid carcinoma030220 oncology & carcinogenesisVaginaCarcinoma Squamous CellVaginoplastyFemalebusinessRare diseaseGynecologic oncology
researchProduct

Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institut…

2016

Abstract Study Objective To investigate the feasibility and safety of laparoscopic cytoreduction in ovarian cancer patients with localized carcinomatosis or lymph node involvement. Design Retrospective cohort study (Canadian Task Force classification II-2). Setting Multi-institutional study performed in 6 referral gynecologic oncology units. Patients Between June 2005 and December 2014, preoperatively presumed early-stage ovarian cancer patients, who accidentally revealed localized carcinomatosis or lymph node involvement at laparoscopic evaluation or at postoperative pathological examination managed by the laparoscopic approach. Interventions All patients with limited carcinomatosis and/or…

Adultmedicine.medical_specialtymedicine.medical_treatmentLaparoscopic cytoreduction; Laparoscopy; Minimally invasive surgery; Ovarian cancer; Adult; Aged; Aged 80 and over; Carcinoma; Cytoreduction Surgical Procedures; Disease-Free Survival; Feasibility Studies; Female; Humans; Laparoscopy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence Local; Ovarian Neoplasms; Retrospective Studies; Young AdultGynecologic oncologyDisease-Free SurvivalLaparoscopic cytoreduction Laparoscopy Minimally invasive surgery Ovarian cancerYoung Adult03 medical and health sciences0302 clinical medicineMinimally invasive surgeryOvarian cancerCytoreduction Surgical Procedures80 and overmedicineCarcinomaHumansLymph nodeSurvival rateAgedRetrospective StudiesAged 80 and overOvarian Neoplasms030219 obstetrics & reproductive medicinebusiness.industryCarcinomaObstetrics and GynecologyRetrospective cohort studyCytoreduction Surgical ProceduresMiddle Agedmedicine.diseaseSurgeryNeoplasm Recurrencemedicine.anatomical_structureLocalLaparoscopic cytoreductionLymphatic Metastasis030220 oncology & carcinogenesisFeasibility StudiesFemaleLaparoscopyLymphadenectomyLymph NodesNeoplasm Recurrence LocalbusinessOvarian cancerJournal of Minimally Invasive Gynecology
researchProduct

Minilaparoscopic aortic lymphadenectomy.

2015

Abstract Study Objective To show the feasibility of performing aortic lymphadenectomy with 3-mm instruments in gynecologic malignancies. Patient A 43-year-old, multiparous patient with serous ovarian cancer grading 2, Federation Internationale de Gynecologie et d'Obstetrique stage IC (intraoperative spillage). Intervention The patient was accidentally diagnosed with ovarian cancer after a right adnexectomy performed for an ovarian cyst. Once referred to our center, a delayed surgical staging was planned including total hysterectomy, left adnexectomy, aortic and pelvic lymphadenectomy, peritoneal biopsies, and total omentectomy. Minilaparoscopy was believed to be feasible to achieve it. Meas…

Adultmedicine.medical_specialtymedicine.medical_treatmentOperative TimeSerous ovarian cancermedicineHumansGynecologic cancerGrading (tumors)AortaOvarian NeoplasmsHysterectomyOvarian cystbusiness.industryOvarian NeoplasmMedicine (all)Lymph NodeObstetrics and GynecologyPostoperative complicationmedicine.diseaseSurgeryminilaparoscopicMinilaparoscopyFeasibility StudieSettore MED/40 - GINECOLOGIA E OSTETRICIATreatment OutcomeChemotherapy AdjuvantOperative timeFeasibility StudiesLymph Node ExcisionLymphadenectomyFemaleLaparoscopyLymph NodesNeoplasm Recurrence LocalOvarian cancerbusinessaortic lymphadenectomyHumanJournal of minimally invasive gynecology
researchProduct

In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared …

2008

Rituximab is a chimeric monoclonal antibody directed against human CD20 antigen, which is expressed on B-cell lymphocytes and on the majority of B-cell lymphoid malignancies. Herein we report the conjugate of rituximab with the near-infrared (NIR) fluorophore Cy5.5 (RI-Cy5.5) as a tool for in vitro, in vivo, and ex vivo NIR time-domain (TD) optical imaging. In vitro, RI-Cy5.5 retained biologic activity and led to elevated cell-associated fluorescence on tumor cells. In vivo, TD optical imaging analysis of RI-Cy5.5 injected into lymphoma-bearing mice revealed a slow tumor uptake and a specific long-lasting persistence of the probe within the tumor. Biodistribution studies after intraperiton…

BiodistributionPathologymedicine.medical_specialtylcsh:Medical technologyLymphomamedicine.medical_treatmentIntraperitoneal injectionTransplantation HeterologousBiomedical EngineeringCarbocyanineMice SCIDBiologyIntestinal absorptionAntibodies Monoclonal Murine-DerivedMiceIn vivomedicineAnimalsHumansRadiology Nuclear Medicine and imagingAnimals; Antibodies Monoclonal; Antibodies Monoclonal Murine-Derived; Binding Sites; Carbocyanines; Cell Division; Female; Humans; Immunohistochemistry; Intestinal Absorption; Lymph Nodes; Lymphoma; Mice; Mice SCID; Neoplasm Transplantation; Rituximab; Transplantation Heterologouslcsh:QH301-705.5Binding SitesAnimaltechnology industry and agricultureBinding SiteAntibodies MonoclonalLymph NodeCarbocyaninesCondensed Matter PhysicsImmunohistochemistryTransplantationlcsh:Biology (General)lcsh:R855-855.5Intestinal AbsorptionMonoclonalMolecular MedicineImmunohistochemistryFemaleLymph NodesRituximabEx vivoCell DivisionNeoplasm TransplantationBiotechnologyHuman
researchProduct

La terapia adiuvante nelle pazienti affette da carcinoma mammario con linfonodi ascellari negativi. Attuale ruolo dei fattori prognostici nella condo…

1994

Breast cancer axillary lymph nodes
researchProduct

Coordinates in the Universe of Node-Negative Breast Cancer Revisited

2009

Abstract We present a global picture of the natural history of node-negative breast cancer in which two of three important biological processes have outstanding prognostic consequences. We propose that the transition from slow to fast proliferation of the tumor leads to the most dramatic aggravation of prognosis. Second, immune cell infiltration is of major importance to prevent disease progression in fast-proliferating breast carcinomas, regardless of estrogen receptor status. In the absence of endocrine treatment, steroid hormone receptor expression as a third axis is of limited prognostic importance. Dissecting tumors according to these three major biological axes will allow further unde…

CA15-3Cancer ResearchPathologymedicine.medical_specialtySteroid hormone receptorbusiness.industryCancerBreast Neoplasmsmedicine.diseaseBreast cancerOncologyTumor progressionLymphatic MetastasismedicineCancer researchHumansEndocrine systemFemaleLymph NodesBreast diseasebusinessEstrogen Receptor StatusCancer Research
researchProduct

A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells

2017

A MUC1 anticancer vaccine equipped with covalently linked divalent mannose ligands was found to improve the antigen uptake and presentation by targeting mannose-receptor-positive macrophages and dendritic cells. It induced much stronger specific IgG immune responses in mice than the non-mannosylated reference vaccine. Mannose coupling also led to increased numbers of macrophages, dendritic cells, and CD4+ T cells in the local lymph organs. Comparison of di- and tetravalent mannose ligands revealed an increased binding of the tetravalent version, suggesting that higher valency improves binding to the mannose receptor. The mannose-coupled vaccine and the non-mannosylated reference vaccine ind…

CD4-Positive T-Lymphocytes0301 basic medicinemedicine.medical_treatmentMannoseEnzyme-Linked Immunosorbent AssayReceptors Cell SurfaceLigands010402 general chemistryCancer Vaccines01 natural sciencesBiochemistryDivalentMice03 medical and health scienceschemistry.chemical_compoundImmune systemCancer immunotherapyDrug DiscoverymedicineAnimalsHumansLectins C-TypeGeneral Pharmacology Toxicology and PharmaceuticsMUC1Pharmacologychemistry.chemical_classificationMice Inbred BALB CbiologyChemistryMacrophagesMucin-1Organic ChemistryDendritic CellsMolecular biology0104 chemical sciencesMannose-Binding Lectins030104 developmental biologyLymphatic systemImmunoglobulin GImmunologyMCF-7 Cellsbiology.proteinMolecular MedicineLymph NodesAntibodyMannoseMannose ReceptorMannose receptorProtein BindingChemMedChem
researchProduct

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injec…

2001

Dendritic cells (DCs) elicit potent anti-tumoral T-cell responses in vitro and in vivo. However, different types of DC have yet to be compared for their capacity to induce anti-tumor responses in vivo at different developmental stages. Herein, we correlated the efficiencies of different types of monocyte-derived DC as vaccines on the resulting anti-tumor immune responses in vivo. Immature and mature DCs were separately pulsed with a peptide derived from tyrosinase, MelanA/MART-1 or MAGE-1 and a recall antigen. Both DC populations were injected every 2 weeks in different lymph nodes of the same patient. Immune responses were monitored before, during and after vaccination. Mature DCs induced …

CD4-Positive T-LymphocytesCancer Researchmedicine.medical_treatmentT cellchemical and pharmacologic phenomenaCD8-Positive T-LymphocytesInterferon-gammaImmune systemAdjuvants ImmunologicAntigenAntigens NeoplasmHumansMedicineCytotoxic T cellAntigen-presenting cellMelanomaNeoplasm Stagingbusiness.industryDendritic CellsImmunotherapyDendritic cellNeoplasm Proteinsmedicine.anatomical_structureOncologyImmunologyImmunizationLymph NodesPeptidesbusinessMelanoma-Specific AntigensCD8T-Lymphocytes CytotoxicInternational Journal of Cancer
researchProduct

Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-gamma and interleukin-12-deficient mice to naive recipients.

2008

We investigated the possibility of transfer immunity from Cryptosporidium parvum-infected interferon-gamma (GKO) and interleukin-12p40 (IL-12KO) deficient C57BL/6 mice to naive mice by transfer of intraepithelial lymphocytes (IELs) and CD4(+) T cells from spleen and mesenteric lymph nodes (MLNs). Three days after the transfer recipients were infected with C. parvum. IELs isolated from GKO donor mice after resolution of infection (day 15) but not at the peak of infection (day 8) significantly reduced the parasite load in recipient mice. In IL-12KO mice, IELs and also CD4(+) T cells isolated from the spleen and MLNs of donor mice at the peak of infection (day 5) and after resolution (day 15) …

CD4-Positive T-LymphocytesMaleAdoptive cell transferCryptosporidiosisSpleenHost-Parasite InteractionsInterferon-gammaMiceImmunityCell Movementparasitic diseasesmedicineMesenteric lymph nodesAnimalsImmunity MucosalCryptosporidium parvumMice KnockoutGeneral VeterinaryGeneral Immunology and MicrobiologybiologyImmunomagnetic SeparationPublic Health Environmental and Occupational Healthbiology.organism_classificationAdoptive TransferInterleukin-12Mice Inbred C57BLInfectious Diseasesmedicine.anatomical_structureCryptosporidium parvumAdoptive immunityImmunologyInterleukin 12Molecular MedicineIntraepithelial lymphocyteFemaleLymph NodesSpleenVaccine
researchProduct

Angioimmunoblastic T-cell lymphoma

2008

Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive neoplasm clinically characterized by sudden onset of constitutional symptoms, lymphadenopathy, hepatosplenomegaly, frequent autoimmune phenomena, particularly hemolytic anemia and thrombocytopenia, and polyclonal hypergammaglobulinemia. The lymph node histological picture is also distinctive, constituted by a polymorphic infiltrate, a marked proliferation of high endothelial venules, and a dense meshwork of dentritic cells. The neoplastic CD4+ T-cells represent a minority of the lymph node cell population; its detection is facilitated by the aberrant expression of CD10. Almost all cases arbor an EBV infected B-cell populatio…

CD4-Positive T-LymphocytesMaleEpstein-Barr Virus InfectionsPathologyAutologous transplantHerpesvirus 4 HumanHepatosplenomegalyImmunosuppressive AgentEpstein-Barr Virus InfectionHypergammaglobulinemiaLymph nodeNon-Hodgkin lymphomaAngioimmunoblastic lymphomaB-Lymphocyteseducation.field_of_studyB-LymphocyteLymph NodeHematologyThalidomideSurvival RateTransplantation Autologoumedicine.anatomical_structureOncologyCD4-Positive T-LymphocyteFemaleNeprilysinmedicine.symptomImmunosuppressive AgentsHumanmedicine.medical_specialtyAngioimmunoblastic T-cell lymphomaPopulationHigh endothelial venulesDendritic CellLymphoma T-CellTransplantation AutologousmedicineHumanseducationCell Proliferationbusiness.industryPeripheral T-cell lymphomaDendritic Cellsmedicine.diseasePeripheral T-cell lymphomaLymphomaTransplantationImmunologyLymph NodesGeriatrics and GerontologybusinessStem Cell Transplantation
researchProduct